Treace Medical Concepts (TMCI) Revenue (2020 - 2026)

Treace Medical Concepts (TMCI) has 7 years of Revenue data on file, last reported at $47.2 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 10.22% year-over-year to $47.2 million; the trailing twelve-month figure through Mar 2026 stood at $207.3 million (down 1.66% YoY), and the FY2025 full-year result was $212.7 million, up 1.59% from the prior year.
• Revenue for Q1 2026 stood at $47.2 million, down from $62.5 million in the prior quarter.
• Across five years, Revenue topped out at $68.7 million in Q4 2024 and bottomed at $29.0 million in Q1 2022.
• The 5-year median for Revenue is $47.2 million (2026), against an average of $47.0 million.
• The widest annual swing landed in 2022, when Revenue jumped 55.27%; it then slipped 10.22% in 2026.
• A 5-year view of Revenue shows it stood at $49.8 million in 2022, then advanced by 25.0% to $62.2 million in 2023, then advanced by 10.44% to $68.7 million in 2024, then fell by 9.01% to $62.5 million in 2025, then declined by 24.51% to $47.2 million in 2026.
• The last three Revenue figures came in at $47.2 million (Q1 2026), $62.5 million (Q4 2025), and $50.2 million (Q3 2025), per Business Quant data.

Peer Comparison